HCW Biologics Inc. Common Stock — Quarterly Financial Statements (NASDAQ:HCWB) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 2.2694 M
Employee 35
Founded 2018
CEO N/A
Website www.hcwbiologics.com
Headquarter Delaware, United States
FIGI BBG011769443
Industry Biotechnology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

Price to earnings ratio

-0.09

Price to sales ratio

37.54

News

HCW Biologics (HCWB) Stock Is Trending Overnight — Here's Why It Moved Over 122% In After-Hours Session -

HCW Biologics receives $7M upfront fee from China licensee

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.83%

HCW Biologics’ compound shows promise in CAR-T cell production

HCW Biologics enters $7 million licensing deal with China-based Trimmune

HCW Biologics reports steps to regain Nasdaq compliance following equity transactions

HCW Biologics secures $4 million through warrant exercise agreement

HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech

HCW Biologics doses first patient in alopecia areata clinical trial

Wugen secures $115 million in equity financing led by Fidelity

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.59%

HCW Biologics and WY Biotech discuss further changes to license agreement